Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision MedicineREAD THE PR
70% of Life Sciences Companies Use Digital Pathology
HNL Lab Medicine to Go 100% Digital
The Significance of Robust Validation in Automated Quality Control Solutions
How is artificial intelligence rising to the challenge in breast cancer diagnosis?
Survey Says…
Introducing Customized Sensitivity for Automated Quality Control
Five Steps to Firmly and Transparently Lead Your Digitization Journey
Wisdom From The Women Leading The AI Industry, with Julianna Ianni of Proscia
The Importance of Quality Control in Digital Pathology
Women in AI: Breaking the Mold | Julianna Ianni, Proscia

Our website uses cookies. By using this site, you agree to its use of cookies.